These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 10449755)
1. Mechanism for elimination of a tumor suppressor: aberrant splicing of a brain-specific exon causes loss of function of Bin1 in melanoma. Ge K; DuHadaway J; Du W; Herlyn M; Rodeck U; Prendergast GC Proc Natl Acad Sci U S A; 1999 Aug; 96(17):9689-94. PubMed ID: 10449755 [TBL] [Abstract][Full Text] [Related]
2. The c-Myc-interacting adaptor protein Bin1 activates a caspase-independent cell death program. Elliott K; Ge K; Du W; Prendergast GC Oncogene; 2000 Sep; 19(41):4669-84. PubMed ID: 11032017 [TBL] [Abstract][Full Text] [Related]
3. Expression of a MYCN-interacting isoform of the tumor suppressor BIN1 is reduced in neuroblastomas with unfavorable biological features. Tajiri T; Liu X; Thompson PM; Tanaka S; Suita S; Zhao H; Maris JM; Prendergast GC; Hogarty MD Clin Cancer Res; 2003 Aug; 9(9):3345-55. PubMed ID: 12960121 [TBL] [Abstract][Full Text] [Related]
4. Losses of the tumor suppressor BIN1 in breast carcinoma are frequent and reflect deficits in programmed cell death capacity. Ge K; Duhadaway J; Sakamuro D; Wechsler-Reya R; Reynolds C; Prendergast GC Int J Cancer; 2000 Feb; 85(3):376-83. PubMed ID: 10652430 [TBL] [Abstract][Full Text] [Related]
5. Bin1 mediates apoptosis by c-Myc in transformed primary cells. DuHadaway JB; Sakamuro D; Ewert DL; Prendergast GC Cancer Res; 2001 Apr; 61(7):3151-6. PubMed ID: 11306501 [TBL] [Abstract][Full Text] [Related]
6. Structural analysis of the human BIN1 gene. Evidence for tissue-specific transcriptional regulation and alternate RNA splicing. Wechsler-Reya R; Sakamuro D; Zhang J; Duhadaway J; Prendergast GC J Biol Chem; 1997 Dec; 272(50):31453-8. PubMed ID: 9395479 [TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity and tumor suppressor activity of Bin1 in prostate carcinoma. Ge K; Minhas F; Duhadaway J; Mao NC; Wilson D; Buccafusca R; Sakamuro D; Nelson P; Malkowicz SB; Tomaszewski J; Prendergast GC Int J Cancer; 2000 Apr; 86(2):155-61. PubMed ID: 10738240 [TBL] [Abstract][Full Text] [Related]
8. A structure-based model of the c-Myc/Bin1 protein interaction shows alternative splicing of Bin1 and c-Myc phosphorylation are key binding determinants. Pineda-Lucena A; Ho CS; Mao DY; Sheng Y; Laister RC; Muhandiram R; Lu Y; Seet BT; Katz S; Szyperski T; Penn LZ; Arrowsmith CH J Mol Biol; 2005 Aug; 351(1):182-94. PubMed ID: 15992821 [TBL] [Abstract][Full Text] [Related]
9. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism. Kinney EL; Tanida S; Rodrigue AA; Johnson JK; Tompkins VS; Sakamuro D J Cell Physiol; 2008 Sep; 216(3):621-31. PubMed ID: 18348166 [TBL] [Abstract][Full Text] [Related]
10. Transformation-selective apoptotic program triggered by farnesyltransferase inhibitors requires Bin1. DuHadaway JB; Du W; Donover S; Baker J; Liu AX; Sharp DM; Muller AJ; Prendergast GC Oncogene; 2003 Jun; 22(23):3578-88. PubMed ID: 12789266 [TBL] [Abstract][Full Text] [Related]
11. Bau, a splice form of Neurabin-I that interacts with the tumor suppressor Bin1, inhibits malignant cell transformation. Duhadaway J; Rowe F; Elliott K; Mao NC; Prendergast GC Cell Adhes Commun; 1999; 7(2):99-110. PubMed ID: 10427963 [TBL] [Abstract][Full Text] [Related]
12. Bin1 functionally interacts with Myc and inhibits cell proliferation via multiple mechanisms. Elliott K; Sakamuro D; Basu A; Du W; Wunner W; Staller P; Gaubatz S; Zhang H; Prochownik E; Eilers M; Prendergast GC Oncogene; 1999 Jun; 18(24):3564-73. PubMed ID: 10380878 [TBL] [Abstract][Full Text] [Related]
13. SRSF1-dependent alternative splicing attenuates BIN1 expression in non-small cell lung cancer. Wang J; Liu T; Wang M; Lv W; Wang Y; Jia Y; Zhang R; Liu L J Cell Biochem; 2020 Feb; 121(2):946-953. PubMed ID: 31478261 [TBL] [Abstract][Full Text] [Related]
14. BIN1 is a novel MYC-interacting protein with features of a tumour suppressor. Sakamuro D; Elliott KJ; Wechsler-Reya R; Prendergast GC Nat Genet; 1996 Sep; 14(1):69-77. PubMed ID: 8782822 [TBL] [Abstract][Full Text] [Related]
15. Splicing Regulator p54 Hu Z; Dong L; Li S; Li Z; Qiao Y; Li Y; Ding J; Chen Z; Wu Y; Wang Z; Huang S; Gao Q; Zhao Y; He X Hepatology; 2020 Aug; 72(2):548-568. PubMed ID: 31815296 [TBL] [Abstract][Full Text] [Related]
16. Identification of tyrosine kinase, HCK, and tumor suppressor, BIN1, as potential mediators of AHI-1 oncogene in primary and transformed CTCL cells. Kennah E; Ringrose A; Zhou LL; Esmailzadeh S; Qian H; Su MW; Zhou Y; Jiang X Blood; 2009 May; 113(19):4646-55. PubMed ID: 19211505 [TBL] [Abstract][Full Text] [Related]
17. Investigation of the expression of Bin1, a putative suppressor, in human hepatoma cells. Livezey KW; Negorev D; Simon D Cancer Genet Cytogenet; 2000 Jan; 116(1):35-9. PubMed ID: 10616529 [TBL] [Abstract][Full Text] [Related]
18. Targeted deletion of the suppressor gene bin1/amphiphysin2 accentuates the neoplastic character of transformed mouse fibroblasts. Muller AJ; DuHadaway JB; Donover PS; Sutanto-Ward E; Prendergast GC Cancer Biol Ther; 2004 Dec; 3(12):1236-42. PubMed ID: 15611650 [TBL] [Abstract][Full Text] [Related]
19. The putative tumor suppressor BIN1 is a short-lived nuclear phosphoprotein, the localization of which is altered in malignant cells. Wechsler-Reya R; Elliott K; Herlyn M; Prendergast GC Cancer Res; 1997 Aug; 57(15):3258-63. PubMed ID: 9242458 [TBL] [Abstract][Full Text] [Related]
20. Induction of apoptosis and differentiation in neuroblastoma and astrocytoma cells by the overexpression of Bin1, a novel Myc interacting protein. Galderisi U; Di Bernardo G; Cipollaro M; Jori FP; Piegari E; Cascino A; Peluso G; Melone MA J Cell Biochem; 1999 Sep; 74(3):313-22. PubMed ID: 10412034 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]